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otherwise be immunogenic. These issues have by no means been 
SFTPMWFE BT JU JT EJG¾DVMU UP EFWJTF OPOIVNBO FYQFSJNFOUT UIBU
provide clear guidance on this issue. However, for many reasons 
cartilage would be a good candidate for trial, as the chondrocytes even 
in an immature ECM, are in an environment devoid of blood vessels 
and away from the circulation that contains the cells necessary to 
initiate an immune response. So it might be expected to be a site 
of low immunogenic risk, requiring minimal immuno-suppression. It 
is therefore an intriguing challenge to establish if stem cells from 
unrelated individuals can be used for the repair of tissues like 
cartilage, as this would open the way to their use on a much broader 
scale because of the economies possible with a banked cell supply; 
but that is a hope for tomorrow and not a promise for today. 
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4.1
Genetically engineered elastin-like polypeptides for cartilage 
tissue regeneration 
L.A. Setton, D.L. Nettles, D.W. Lim, F. Guilak, A. Chilkoti, United 
States of America 
Injectable, in situ forming scaffolds have long been of interest for 
promoting regeneration of focal cartilage defects. With liquid-like 
properties that allow mixing with cells or other factors, these materials 
DBO CF JOKFDUFE UP FOBCMF DPNQMFUF ¾MMJOH PG JSSFHVMBSMZTIBQFE
defects and the delivery of cell or bioactive drugs that could enhance 
integration of newly generated tissue with the existing native tissue. 
Additional advantages are the opportunity for these scaffolds to 
contribute to preservation of mechanical integrity and maintenance 
of cell phenotypes. Many hydrogels capable of in situ formation or 
crosslinking have been evaluated for potential to promote cartilage 
matrix regeneration, including alginate23, poly(ethylene oxide)8,
poly(N-isopropylacrylamide)27 ¾CSJO26, hyaluronic acid21, collagen 
gels18, 33, chitosan7,19, poly(propylene fumarate)28, and poly(vinyl 
alcohol)24. These polymers share the characteristics that they form 
three-dimensional hydrogels in situ of high water content that 
support rounded cell morphologies and rapid diffusion of soluble 
nutrients. However, other properties of these hydrogels differ 
including biocompatibility, degradation, surface interaction, and cell 
recognition characteristics. In situ forming materials also have the 
potential to facilitate tissue regeneration in 2nd and 3rd generation 
procedures for autologous chondrocyte delivery, where various 
biological or polymer membranes or scaffolds have been used to 
preserve retention of the delivered cells6, 14.
Our laboratory has developed a class of polypeptide gels for the 
purpose of promoting cartilage matrix regeneration, biocompatible 
cell delivery, and tissue integration. ELPs consist of oligomeric 
repeats of the pentapeptide sequence Val-Pro-Gly-Xaa-Gly, where 
Xaa is any amino acid except proline30. This is a naturally occurring 
sequence in the protein elastin contained in muscle, ligaments, 
cartilage and numerous other soft tissues. ELPs have been shown 
not to illicit an antibody response upon implantation in multiple 
animal and human applications31, and have been considered to 
be non-immunogenic. ELPs are environmentally responsive, as 
they exhibit a reversible inverse phase transition at a temperature 
(Tt) above which they undergo hydrophobic collapse and form 
intermolecular associations that result in an “aggregated” mass11.
By designing the transition to occur at physiological temperatures, 
the environmental responsiveness of ELPs enables in situ formation 
and physical property changes that contribute to load-bearing and 
cell entrapment3-5. ELPs may be synthesized genetically, and so 
designed at the genetic level to control molecular weight, reactive 
crosslinking sites, and chemistry of the amino acid residues16,17.
In this paper, we review our experience with uncrosslinked and 
crosslinkable ELPs for an ability to entrap chondrocytes and adult 
stem cells, contribute to mechanical load-bearing properties, and 
promote matrix integration in a goat model of osteochondral defect-
¾MMJOH5IFSFTVMUTJMMVTUSBUFUIFGBWPSBCMFDIBSBDUFSJTUJDTBOEGBDJMF
synthesis of an in situ forming, biocompatible hydrogel that can 
assist cartilage matrix regeneration in multiple ways. 
Elastin-Like Polypeptide Gene Design and Synthesis. Genes have 
been designed to encode a wide range of ELP proteins with different 
guest residue sequences and combinations thereof17. For a given 
&-1HFOFTFODPEJOHUIFUBSHFUFEQFOUBQFQUJEFTFRVFODFBSF¾STU
constructed from synthetic oligonucleotides, and oligomerized 
by recursive directional ligation17. In our laboratory, peptides 
IBWF CFFO FYQSFTTFE JO & DPMJ &-1T NBZ CF FBTJMZ QVSJ¾FE CZ
inverse transition cycling. This procedure consists of a series of 
cyclic temperature changes that drive the transitioning of the ELP 
sequence, but not other proteins resulting from the expression. After 
only two sequences of temperature shifts above and below the Tt 
(generally between 28-34°C) the purity of the resulting ELP product 
has been shown to be excellent, with endotoxin levels far below FDA 
allowable limits for medical devices15.
Chondrocyte and Stem Cell Encapsulation for In Vitro Culture. ELPs 
were designed with Val, Gly and Ala in a 5:2:3 ratio, respectively, 
at the guest residue position of the pentapeptide (36 kDa MW). 
These ELPs give rise to a target Tt of 35°C at a solution concentration 
of 50 mg/ml and so enable their use for in situ forming gels at 
physiological temperatures5. Physical characteristics of the ELPs 
were obtained by evaluating the rheological properties above and 
below the Tt using viscometry experiments. Below Tt, the apparent 
viscosity |Ș*| and dynamic shear modulus |G*| were sensitive to ELP 
concentration and exhibited a 2-fold increase in magnitude with a 
4-fold increase in concentration. However, by increasing Tt to 37°C, 
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the ELP experienced a 1000-fold increase in values for viscosity and 
moduli5. This dramatic increase in stiffness and viscosity for the 
uncrosslinked ELP gels alone may be functionally important for cell 
delivery to tissue defects, and fall within the range of values reported 
for other hydrogel materials. 
In one study5, primary chondrocytes from a porcine source were 
FOUSBQQFE JO BO &-1 TPMVUJPO BU WFSZ IJHI FG¾DJFODZ 	 PG UIF
chondrocytes at 1 x 106 cells/ml ELP at ~50 mg/ml). The cells were 
mixed with ELP at room temperature, and allowed to incubate at 
37°C for a one-hour period. When cultured in vitro for 2 weeks, 
ELP/chondrocyte constructs were found to promote the rounded 
chondrocyte morphology and to stain positively for toluidine blue 
BOE .BTTPOµT USJDISPNF SF¿FDUJOH UIF BDDVNVMBUJPO PG OFXMZ
synthesized sulfated glycosaminoglycans (S-GAG) and collagenous 
QSPUFJOT 5IJTXBT DPO¾SNFECZNFBTVSFTPG4("(BOE DPMMBHFO
content, corresponding to 10 µg/µg DNA (~ 1% dry wt.), and ~4.4 
µg collagen /µgDNA, values lower than that reported for pre-formed 
scaffolds of poly(glycolic) acid25 or silk34. This work was focused on a 
short incubation time, however, and was important for demonstrating 
that ELPs support the viability of chondrocytes, and do not elicit 
DZUPUPYJDJUZXIJDIJTDPOTJTUFOUXJUIUIFJSQSP¾MFBTCJPDPNQBUJCMF
natural materials. 
In additional work with the uncrosslinked ELPs, we turned our 
interests to an adult stem cell source derived from adipose tissue 
(hADAS) shown to contain multipotent progenitor cells that can 
differentiate into phenotypic chondrocytes9, 10, 35. The potential 
use of these cells for tissue engineering is attractive, since 
adipose tissue can be readily obtained, and autologous cells are 
immunocompatible. 
hADAS cells were obtained and expanded for 2-3 passages as 
described previously2, and encapsulated in ELP solutions as described 
above. An important objective of this work was to compare constructs 
cultured in “standard media” consisting of media, serum and 
ascorbate to promote chondrogenesis, versus media with the added 
“chondrogenic” supplements of TGF-ȕ1 and dexamethasone believed 
necessary to promote stem cell differentiation into chondrocytes. In 
measures of biochemical composition and histological appearance, 
constructs were not found to differ between constructs grown in 
chondrogenic or standard media after 2 weeks of culture. Values for 
biochemical composition also compared well with previous reports 
for hADAS cells cultured in alginate under chondrogenic conditions, 
XJUI ¾OEJOHT UIBU GFMM BSPVOE  H 4("(H %/" BOE _ H
collagen/µg DNA. Immunohistochemical labeling of collagens type 
I and II showed that the majority of matrix formed by constructs 
consisted of type II collagen, with no detectable amount of type I 
DPMMBHFO 5IF ¾OEJOHT GSPN UIJT TUVEZ EFNPOTUSBUFE UIF BCJMJUZ
of ELPs to induce and support the chondrocytic differentiation of 
human adipose tissue-derived adult stem cells in vitro in the absence 
of exogenous chondrogenic supplements, promoting interest in the 
use of ELPs as a carrier for stem cell delivery to cartilage defect sites 
to promote cell-mediated matrix regeneration. 
$IFNJDBM BOE &O[ZNBUJD $SPTTMJOLJOH PG &-1T 8IJMF UIFTF ¾STU
studies showed that ELPs provide a physical environment conducive 
for cell viability, chondrocyte differentiation and cartilage matrix 
synthesis, a major limitation of the ELP gels was felt to be their 
inability to support high loads typical of cartilage weight-bearing 
in vivo. Thus, we explored several methods to crosslink ELPs in an 
attempt to increase mechanical integrity. An advantage of ELPs is 
an ability to incorporate moieties for crosslinking through genetic 
engineering, as well as sites for controlled degradation or ligand 
QSFTFOUBUJPO*OB¾STUTUVEZHFOFTGPS&-1XFSFEFTJHOFEUPFODPEF
GPS B QSFDJTFMZ TQFDJ¾FE OVNCFS PG BNJOF HSPVQT 	-ZT
 UIBUXFSF
periodically arranged along the primary amino acid sequence of the 
biopolymer29. ELPs were chemically crosslinked using a trifunctional 
crosslinker (tris-succinimidyl amino-triacetate, TSAT) to generate 
hydrogels of high stiffness, about two orders of magnitude greater 
than uncrosslinked ELPs. As organic solvents were necessary to 
create these chemically crosslinked gels, however, a biocompatible 
crosslinking process was sought that would enable cell encapsulation 
or in situ polymerization. 
In a later study, we chose enzymatic crosslinking to promote 
formation of ELP hydrogels. While many enzymes have been 
JEFOUJ¾FE BT DBUBMZTUT PG DSPTTMJOLJOH SFBDUJPOT XF DIPTF IVNBO
tissue transglutaminase (tTG), which catalyzes a calcium-dependent 
reaction that generates a Ȗ-glutamyl-İ-lysyl covalent bond between 
peptide-bound glutamine residues and primary amines13. tTG is 
expressed in a variety of cartilage tissues1 and many components 
PGDBSUJMBHFNBUSJY	FH¾CSPOFDUJOBOEDPMMBHFOT*****7BOE9*
BSF
crosslinking substrates for this enzyme. Two genes were synthesized 
for ELPs containing periodic glutamine and valine, or lysine and 
valine in the guest residue positions. When the two ELPs were mixed 
together, they were capable of crosslinking following addition of 
tTG. Primary porcine chondrocytes were added to a mixture of ELP 
solutions (1:1 ratio of the polymers) and placed in a 37 °C incubator 
to trigger the ELP phase transition and cell encapsulation process. 
The resulting pellet was re-solubilized at room temperature and 
NJYFEXJUIQVSJ¾FE U5( JODBMDJVNGSFFCVGGFS 	DBMDJVNDBO USJHHFS
the activation of tTG). Crosslinking was then initiated by the 
addition of 10 mM CaCl2 at 37°C followed by culture of the ELP gel-
cell constructs. Histological staining of the ELP gel-cell constructs 
showed accumulation of type II collagen-containing cartilaginous 
matrix in the vicinity of encapsulated cells, similar to that seen in the 
uncrosslinked ELPs. There was no evidence of staining for the anti-
collagen I antibody indicating that the accumulated matrix is clearly 
more representative of hyaline cartilage, as in articular cartilage, than 
¾CSPDBSUJMBHF5IFSFXBTBMTPFWJEFODFPGBTUFBEZJODSFBTFJO4("(
per construct dry weight that increased, but to a maximum of 1-2% 
only. In summary, we observed ELP gel formation and chondrocyte 
encapsulation in a biocompatible process, with formation of ELP-cell 
constructs that supported the chondrocyte phenotype and cartilage 
matrix synthesis in vitro, just as for the uncrosslinked form. 
Biocompatible Crosslinking of ELPs. While the intention of tTG 
initiated crosslinking was to increase the mechanical integrity 
of the ELP gels formed in situ, the dynamic shear stiffness of tTG 
crosslinked ELP gels was less than 5 kPa, and thus not considered 
suitable for mechanical load-bearing in a cartilage repair application. 
5IJTSFTVMUFEGSPNQPPSBDUJWBUJPOPGUIFFO[ZNFMBDLPGTQFDJ¾DJUZ
for the substrate, and relatively slow enzyme kinetics. In an effort to 
promote rapid and biocompatible crosslinking, Lys-containing ELPs 
were crosslinked with an amine-reactive trifunctional crosslinker, 
(ȕ-[Tris(hydroxymethyl) phosphino] propionic acid (betaine), THPP. 
The byproducts of this reaction are water and chemically stable 
aminomethyl-phosphines and so are biocompatible for crosslinking 
with cells 12. ELPs crosslinked with this system result in gels having 
mechanical stiffnesses 2-3 orders of magnitude greater than those 
reported for uncrosslinked ELP 12, with compressive stiffness values 
up to 50 kPa particularly for higher polypeptide concentration, 
lower periodicity of crosslinking sites (higher crosslinking density), 
and higher crosslinker-to-reactive amine ratio. These values are 
still one order-of-magnitude lower than corresponding values 
for articular cartilage of 500-1000 kPa, but are close to reported 
values for meniscus and intervertebral disc. Importantly, cells can 
be mixed with both polypeptide and crosslinker, and scaffolds will 
form in times on the order of seconds to minutes, depending on 
ELP sequence, concentration, MW, solution pH, ionic strength, and 
starting temperature.
Our group has also led an effort to develop rapid and non-destructive 
in vitro “screens” of ELP hydrogels for their ability to synthesize 
cartilage matrix. In these tests, eleven different formulations of 
ELPs were used to construct chondrocyte-laden gels crosslinked 
with THPP for in vitro culture, followed by measures of construct 
production and consumption of metabolites (glucose and lactate), 
BOE%/"BOE4("(DPOUFOUTBUFBSMZUJNFQPJOUT	EBZT
'SPN
these data and numerical modeling analyses using neural networks, 
we can conclude that cells are more metabolically active in hydrogels 
at the lower ELP concentrations and accumulate higher amounts of 
4("(BGUFSEBZTJODVMUVSF5IFTF¾OEJOHTJMMVTUSBUFBGVOEBNFOUBM
challenge in working with hydrogels for cell-driven matrix repair, 
that ELP formulations optimal for mechanical load-bearing (higher 
concentrations or higher crosslink densities) are not simultaneously 
appropriate for supporting biosynthesis. The approaches developed 
in our group permit the use of both short term in vitro “screens” 
and a computational model to develop selection criteria that will 
simultaneously optimize mechanical and biological characteristics 
of crosslinked ELPs in longer-term culture settings, in order to move 
forward with a scaffold for cartilage regeneration. 
$SPTTMJOLFE &-1T &WBMVBUFE JO (PBU 0TUFPDIPOESBM %FGFDU ¾MMJOH
Model. While both crosslinked and uncrosslinked ELP gels were 
found to be supportive of cartilage matrix synthesis for chondrocytes 
and stem cells in vitro, it was not known how these results would 
translate to the in vivo setting of a cartilage or osteochondral defect-
¾MMJOHXIFSFNVMUJQMF DFMM QPQVMBUJPOT BOE WBTDVMBS GBDUPST DPVME
contribute to long-term ELP performance. We undertook studies 
PG &-1 PTUFPDIPOESBM EFGFDU¾MMJOH JO B MBSHF EFGFDUNPEFM JO UIF
goat 20, as developed by Jackson and co-workers (2001). Defects 
(6 x 4 mm) were generated on the medial femoral condyle of both 
knees in skeletally mature goats (n=7); defects in one joint were 
¾MMFEXJUI&-1NJYFEXJUI DSPTTMJOLFSXIJMF UIF DPOUSBMBUFSBM KPJOU
was left empty as a control. We selected a high molecular weight 
ELP with a moderate density of crosslinking sites (Lys:Val=1:6, 200 
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mg/ml) for delivery to the defect without any cell supplementation. 
Our goal was to achieve a highly elastic and stiff formulation that 
was still suitably viscous to inject into the defect site; since this was 
an acellular strategy, ELP parameters that contribute to cell viability 
and metabolism were not priorities. 
The ELP/crosslinker solution was easily delivered to osteochondral 
EFGFDUT BOE DSPTTMJOLFE JO MFTT UIBO ¾WF NJOVUFT 3FTVMUT XFSF
evaluated via grading of gross appearance, histology and staining 
GPS UZQFT * BOE ** DPMMBHFO VTJOH B NPEJ¾FE *$34 TDIFNF "U 
NPOUIT&-1¾MMFEEFGFDUTTIPXFETJHOJ¾DBOUMZCFUUFSJOUFHSBUJPOCZ
evaluation of gross and histological appearance, as well as improved 
total and types I & II collagen scores compared to controls. At 6 
NPOUITIPXFWFSUIFIJTUPMPHJDBMBQQFBSBODFPG&-1¾MMFEEFGFDUT
TDPSFE MPXFS GPS BSDIJUFDUVSF BOE QSPUFPHMZDBOT UIBO VO¾MMFE
controls. ELP was observed in defects 7 days after surgery, but was 
largely absent at 3 months, suggesting that ELP-based hydrogels 
were degraded in vivo, consistent with our prior work showing that 
THPP-crosslinked ELPs are susceptible to proteolysis 22.
Summary of Studies and Future Directions. Our experience with 
genetically engineered ELPs has illustrated some favorable features 
of in situ forming scaffolds for assisting cartilage regeneration. 
The liquid-like property of ELPs in aqueous solutions below 
the transition temperature makes mixing with cells and cell 
FODBQTVMBUJPO FG¾DJFOU BOE FYUSFNFMZ TJNQMF0VS JO WJUSP TUVEJFT
demonstrate that ELPs promote cell viability and a chondrocytic 
phenotype as demonstrated by an ability to synthesize cartilage-
TQFDJ¾D FYUSBDFMMVMBS NBUSJY 8IJMF TPNF WBMVFT GPS CJPDIFNJDBM
composition synthesized in vitro compare well with values reported 
for chondrocytes in alginate gels, retention of newly synthesized 
proteoglycan components in the ELP gels can be improved. In our 
work, we have not made use of bioreactors or bioactive factors, both 
shown to be important for promoting more rapid cartilage matrix 
synthesis 32*OEFFEXFIBWFTQFDJ¾DBMMZDIPTFOUPTUVEZTUFNDFMM
culture in ELP gels without bioactive factors (e.g., TGF-ȕ) in order 
to determine the effects of the polypeptide alone for stem cell 
differentiation. We believe that the strength and unique advantages 
of an in situ forming, or in situ crosslinking hydrogel like ELPs will 
lie in its ability to function as an injectable scaffold for cartilage 
tissue engineering through delivery of cells and/or bioactive factors. 
In comparison with synthetic polymers, ELP-derived scaffolds are 
particularly attractive from a macromolecular perspective, because 
their physico-chemical properties are genetically encodable. Thus, 
the transition temperature, the types and number of crosslinking 
sites, and the molecular weight of ELPs may be precisely controlled 
at the amino acid sequence level. This suggests that the important 
mechanical properties of viscosity, stiffness and dissipation for both 
uncrosslinked ELP gels and crosslinked constructs may be similarly 
controlled at the genetic level, permitting unique and precise 
UBSHFUJOH PGNFDIBOJDBM BOE CJPMPHJDBM EFTJHO TQFDJ¾DBUJPOT GPS B
variety of cartilage tissues. Indeed, the animal model results have 
been useful for illustrating the favorable biocompatibility, integration 
and resorption characteristics of the crosslinked ELPs when used as 
in situ crosslinking injectable materials. Despite the high protein 
concentrations and crosslink densities used in the animal model, 
DFMMTXFSFGPVOEUPJO¾MUSBUFUIFIZESPHFMTBTFBSMZBTUISFFNPOUIT
DPO¾SNJOH UIF PCTFSWBUJPO UIBU SFTPSQUJPO BTTJTUT TVQQPSU PG DFMM
viability and new matrix synthesis. Future work will focus on the 
need to optimize both mechanical and biological design criteria for 
BQBSUJDVMBSEFGFDU¾MMJOHBQQMJDBUJPOBTXFMMBTFWBMVBUJPOTPGDFMM
assisted cartilage regeneration through the delivery of cells, and 
incorporation of cell recognition sequences or bioactive drugs that 
can be directly designed into the ELP sequence. 
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5.1
What is the patient’s opinion of their knee? Experience from 
using the knee injury and osteroarthritis outcome score (KOOS) 
E. Roos, Sweden 
The Knee injury and Osteoarthritis Outcome Score (KOOS) is 
increasingly used for evaluation of the patient’s perspective of knee 
injury and knee osteoarthritis. The rational for and the development 
of the KOOS is outlined. Psychometric properties important for use 
in clinical trials are discussed and examples from use in cartilage 
repair, ACL reconstruction, and other interventions are given. 
Development of the KOOS 
The Knee injury and Osteoarthritis Outcome Score (KOOS) was 
developed as an extension of the WOMAC Osteoarthritis Index with 
the purpose of evaluating short-term and long-term symptoms and 
function in subjects with a variety of knee injuries possibly resulting 
JOPTUFPBSUISJUJT5IF,004IPMET¾WFTFQBSBUFMZTDPSFETVCTDBMFT
Pain, other Symptoms, Function in daily living (ADL), Function in Sport 
and Recreation (Sport/Rec), and knee-related Quality of Life (QOL).
The KOOS has been validated for several orthopaedic interventions 
such as anterior cruciate ligament reconstruction (1), meniscectomy 
(2), post-traumatic osteoarthritis (3) and total knee replacement (4). 
In addition the instrument has been used to evaluate a variety of 
other interventions including cartilage repair (5-9), tibial osteotomy 
(10, 11), physical therapy (12), nutritional supplementation (13) and 
glucosamine supplementation (14). The effect size is generally largest 
for the subscale QOL followed by the subscale Pain. The KOOS is a 
valid, reliable and responsive self-administered instrument that can 
be used for short-term and long-term follow-up of several types of 
knee injury including osteoarthritis. 
The main reason for developing a single instrument with the purpose 
of covering several types of knee injury and including osteoarthritis 
(OA), was that traumatic knee injuries often causes concomitant 
damage to multiple structures (ligaments, menisci, cartilage, etc.) 
and frequently lead to the later development of OA. To be able to 
follow patients after a trauma and to gain insight into the change 
of symptoms, function etc. over time, a questionnaire which covers 
both the short-term and long-term consequences is needed. Prior 
instruments such as the Lysholm knee scoring scale (15) have 
focused only on the short-term consequences and instruments 
such as the WOMAC Osteoarthritis Index (16) only on the long-term 
consequences. An instrument intended for follow-up of these patients 
needs to adequately monitor both the acute injury consequences in 
the physically active and younger patients, and the chronic outcome 
in the older. 
To ensure content validity for subjects with ACL injury, meniscus 
injury, and early OA, we reviewed the literature, consulted an expert 
panel, and conducted a pilot study. The literature indicated three 
principal areas of patient-relevant outcomes: symptoms, functional 
status, and satisfaction. An expert panel comprised of patients 
referred to physical therapy because of knee injuries, orthopaedic 
surgeons, and physical therapists from both Sweden and the United 
States, was asked to identify short- and long-term symptoms and 
functional disabilities resulting from a meniscus or ACL injury. Seven 
GBDUPST XFSF JEFOUJ¾FE CZ UIF QBOFM QBJO FBSMZ EJTFBTFTQFDJ¾D
TZNQUPNTMBUFEJTFBTFTQFDJ¾DTZNQUPNT	FHTZNQUPNTPG0"

function, quality of life, activity level, and satisfaction. 
A pilot study was then conducted to identify the subjectively most 
relevant factors among patients with post-traumatic osteoarthritis. 
4FWFOUZ¾WF JOEJWJEVBMT XIP IBE IBENFOJTDVT TVSHFSZ  ZFBST
previously were asked to respond to two questionnaires, both self-
administered. The participants ranged in age from 35 to 76 (mean 

 BOE TIPXFE SBEJPMPHJDBM TJHOT PG LOFF 0" EF¾OFE BT KPJOU
space narrowing and osteophytes. One of the questionnaires, by 
Flandry et al. (17), was constructed to assess symptoms of anterior 
cruciate ligament (ACL) injury and the other, WOMAC Osteoarthritis 
Index (16), for assessing symptoms of knee OA Questions that most 
frequently received high responses, and were thus considered to 
SF¿FDU UIF NPTU QSFEPNJOBOU TZNQUPNT JODMVEFE UIPTF SFMBUJOH
to pain, swelling, stiffness, and the ability to run, jump, kneel, and 
squat. 
5IF,004JTBDPNQSFIFOTJWF JOTUSVNFOU JODMVEJOH¾WFTVCTDBMFT
assessing aspects of knee injury and knee OA considered important 
by patients. Most other instruments used for acute knee injury 
aggregate items measuring different aspects into one score. This 
QSPDFEVSF ¿BUUFOT UIF SFTVMUT BOE NBLFT JOUFSQSFUBUJPO NPSF
EJG¾DVMUTJODFUIFJODMVEFEJUFNTEPOPUBMXBZTDPSSFMBUF5IF,004
JTTFMGBENJOJTUFSFEBOEUBLFTBQQSPYJNBUFMZNJOVUFTUP¾MMPVU
